Chemotherapy of colorectal cancer liver metastases

被引：0

作者：

Glimelius, B ^{[1
]}

机构：

[1] Univ Uppsala Hosp, Sect Oncol, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden

来源：

EJC SUPPLEMENTS | 2003年 / 1卷 / 06期

关键词：

D O I：

10.1016/S1359-6349(03)90021-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：173 / 180

页数：8

共 45 条

[1] Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study [J].

Aranda, E ;

Diaz-Rubio, E ;

Cervantes, A ;

Anton-Torres, A ;

Carrato, A ;

Massuti, T ;

Tabernero, JM ;

Sastre, J ;

Tres, A ;

Aparicio, J ;

Lopez-Vega, JM ;

Barneto, I ;

Garcia-Conde, T .

ANNALS OF ONCOLOGY, 1998, 9 (07) :727-731

[2] The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: Results of a phase III trial [J].

Borner, MM ;

Castiglione, M ;

Bacchi, M ;

Weber, W ;

Herrmann, R ;

Fey, MF ;

Pagani, O ;

Leyvraz, S ;

Morant, R ;

Pestalozzi, B ;

Hanselmann, S ;

Goldhirsch, A .

ANNALS OF ONCOLOGY, 1998, 9 (05) :535-541

[3]

Buyse M, 1996, J NATL CANCER I, V88, P252

[4] Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis [J].

Buyse, M ;

Thirion, P ;

Carlson, RW ;

Burzykowski, T ;

Molenberghs, G ;

Piedbois, P .

LANCET, 2000, 356 (9227) :373-378

[5]

CARMICHAEL J, 1999, P AN M AM SOC CLIN, V18, P1015

[6]

Colorectal Canc Collaborative Grp, 2000, BMJ-BRIT MED J, V321, P531

[7] Final results of a randomised trial comparing 'Tomudex'(R) (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer [J].

Cunningham, D ;

Zalcberg, JR ;

Rath, U ;

Oliver, I ;

vanCutsem, E ;

Svensson, C ;

Seitz, JF ;

Harper, P ;

Kerr, D ;

PerezManga, G .

ANNALS OF ONCOLOGY, 1996, 7 (09) :961-965

[8] Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].

Cunningham, D ;

Pyrhönen, S ;

James, RD ;

Punt, CJA ;

Hickish, TF ;

Heikkila, R ;

Johannesen, TB ;

Starkhammar, H ;

Topham, CA ;

Awad, L ;

Jacques, C ;

Herait, P .

LANCET, 1998, 352 (9138) :1413-1418

[9] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[10] Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study [J].

deGramont, A ;

Basset, JF ;

Milan, C ;

Rougier, P ;

Bouche, O ;

Etienne, PL ;

Morvan, F ;

Louvet, C ;

Guillot, C ;

Francois, E ;

Bedenne, L .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :808-815

← 1 2 3 4 5 →